Sort
30,917 grants matching “tumor microenvironment”
THE ROLE AND MECHANISMS OF CD4+ T CELLS IN ANTITUMOR IMMUNITY
$275,795Rongfu Wang · Baylor College Of Medicine · P01 · FY2009 · CA
CHIMERIC T CELLS TARGETING NEUROBLASTOMA
$275,789Malcolm K Brenner · Baylor College Of Medicine · P01 · FY2009 · CA
Experimental Therapeutics (ET)
$275,704Martin McMahon · Utah State Higher Education System--University Of Utah · P30 · FY2025 · CA
The Role of Monocytes in non-Hodgkin Lymphoma
$275,668Stephen M Ansell · University Of Iowa · P50 · FY2013 · CA
Evading Immune Escape Mechanisms in Dual-Targeted T-cell Therapy for Breast Canc
$275,666Juan Fernando Vera · Baylor College Of Medicine · P50 · FY2016 · CA
The Role of Monocytes in non-Hodgkin Lymphoma
$275,600Stephen M Ansell · University Of Iowa · P50 · FY2015 · CA
Role of a Novel Secreted Protein Tyrosine Kinase in Development
$275,587Malcolm R. Whitman · Harvard Medical School · R21 · FY2015 · DE
TARGETING MYCN PROTEIN WITH SMALL MOLECULES
$275,587William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2014 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$275,576Andrew M Lowy · University Of California, San Diego · R01 · FY2015 · CA
Melanocyte Survival and Transformation: Hypoxia & P13 Kinase/Akt/mTOR Signaling
$275,576Marianne Broome Powell · Stanford University · R01 · FY2010 · CA
(PQA1) Novel epigenetic mechanism mediate metformin inhibition of prostate cancer
$275,552Xin Li · New York University · R01 · FY2013 · CA
Role of Focal Adhesion Kinase In Tumorigenesis
$275,505David D Schlaepfer · University Of California, San Diego · R01 · FY2013 · CA
Tumor microenvironment, tissue liquidity, and cell interaction in prostate cancer
$275,459Ramsey A Foty · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2012 · CA
NF-kB mediated induction of VEGFR-3 and new lymphatic vessels in breast cancer
$275,416Sophia Ran · Southern Illinois University Sch Of Med · R01 · FY2013 · CA
CANCER THERAPY WITH VACCINIA VIRUS EXPRESSING CYTOKINES
$275,400University Of Cincinnati · R01 · FY2001 · CA
CANCER THERAPY WITH VACCINIA VIRUS EXPRESSING CYTOKINES
$275,400University Of Cincinnati · R01 · FY2000 · CA
CANCER THERAPY WITH VACCINIA VIRUS EXPRESSING CYTOKINES
$275,400University Of Cincinnati · R01 · FY2002 · CA
CANCER THERAPY WITH VACCINIA VIRUS EXPRESSING CYTOKINES
$275,400University Of Cincinnati · R01 · FY2003 · CA
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.
$275,381Muller Fabbri · University Of Hawaii At Manoa · R01 · FY2019 · CA
Melanocyte Survival and Transformation: Hypoxia & P13 Kinase/Akt/mTOR Signaling
$275,369Marianne Broome Powell · Stanford University · R01 · FY2009 · CA
Role of Bim in mediating CAM-DR in hematopoietic tumors
$275,344Lori A Hazlehurst · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
RON Receptor in Pancreatic Cancer Biology and Therapy
$275,270Andrew M Lowy · University Of California, San Diego · R01 · FY2014 · CA
NIH Myeloid Malignancy Program
$275,254Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
$275,251Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · NS
Tumor hypoxia promotes acquired resistance to radiation through ferroptosis inhibition
$275,188Albert Koong · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA